|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's range||235.79 - 241.86|
|52-week range||165.75 - 256.62|
|Beta (5Y monthly)||1.38|
|PE ratio (TTM)||37.90|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
RESEARCH TRIANGLE PARK, N.C., January 31, 2023--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the pharmaceutical and broader life sciences industry, today announces the first life sciences industry collaboration with Alibaba Cloud in China. IQVIA and Alibaba Cloud, the digital technology and intelligence backbone of Alibaba Group, will be providing solutions hosted in Mainland China leveraging Salesforce on Alibaba Clou
RESEARCH TRIANGLE PARK, N.C., January 25, 2023--IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV) will announce its fourth-quarter and full-year 2022 financial results before the market opens on Friday, February 10, 2023. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.
RESEARCH TRIANGLE PARK, N.C., January 18, 2023--The total spending and global demand for medicines will increase over the next five years to approximately $1.9 trillion by 2027, according to a new report titled Global Use of Medicines 2023 – Outlook through 2027 from the IQVIA Institute for Human Data Science.